V. Muzio-González

Cuban Abdala vaccine: Effectiveness in preventing severe disease and death from COVID-19 in Havana, Cuba; A cohort study

R. Guinovart-Díaz, M. Pujol, M. Ayala-Avila, 2022, The Lancet Regional Health - Americas.

Phase II randomized controlled trial to evaluate the efficacy and safety of HeberFERON versus Heberon alpha R in symptomatic or asymptomatic patients infected with the SARS-CoV-2 (Study ESPERANZA/HOPE).

F. Hernández-Bernal, G. Guillén-Nieto, Y. Duncan-Roberts, 2020 .

Five years follow-up of patients with non-melanoma skin cancer treated with HeberFERON

C. Valenzuela-Silva, M. rodríguez-garCía, E. García‐Iglesias, 2022, medRxiv.

A combination treatment of IFN-α2b and IFN-γ accelerates viral clearance and control inflammatory response in COVID-19: Preliminary results of a randomized controlled trial

E. Fish, M. Béquet-Romero, F. Hernández-Bernal, 2021 .

Safety, tolerability, and immunogenicity of a SARS-CoV-2 recombinant spike RBD protein vaccine: A randomised, double-blind, placebo-controlled, phase 1-2 clinical trial (ABDALA Study)

F. Hernández-Bernal, Gilda Lemos-Pérez, A. Palenzuela-Diaz, 2021, eClinicalMedicine.

A phase 3, randomised, double-blind, placebo-controlled clinical trial evaluation of the efficacy and safety of a SARS-CoV-2 recombinant spike RBD protein vaccine in adults (ABDALA-3 study)

María-Concepción Martínez-Rodríguez, F. Hernández-Bernal, Ernesto Rodríguez-Martínez, 2023, Lancet regional health. Americas.

Phase I Study of CIGB-300 AdministeredIntravenously in Patients with Relapsed/Refractory Solid Tumors

D. Alonso, L. González-Méndez, C. Valenzuela-Silva, 2018 .

Combination therapy of Epidermal Growth Factor and Growth Hormone-Releasing Hexapeptide in acute ischemic stroke: a phase I/II non-blinded, randomized clinical trial

F. Hernández-Bernal, V. Muzio-González, Nelvys Subirós-Martínez, 2024, Frontiers in Neurology.